Log In
BCIQ
Print this Print this
 

IV SCY-078

  Manage Alerts
Collapse Summary General Information
Company Scynexis Inc.
DescriptionSemi-synthetic derivative of enfumafungin, a beta 1,3-D-glucan synthase inhibitor
Molecular Target Beta 1,3-D-glucan synthase
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today